These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 24399247)
21. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. Chung KF J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339 [TBL] [Abstract][Full Text] [Related]
22. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Gans MD; Gavrilova T Paediatr Respir Rev; 2020 Nov; 36():118-127. PubMed ID: 31678040 [TBL] [Abstract][Full Text] [Related]
23. Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm. Colavita AM; Reinach AJ; Peters SP Clin Chest Med; 2000 Jun; 21(2):263-77, viii. PubMed ID: 10907587 [TBL] [Abstract][Full Text] [Related]
24. Introduction to asthma and phenotyping. Pillai RA; Calhoun WJ Adv Exp Med Biol; 2014; 795():5-15. PubMed ID: 24162899 [TBL] [Abstract][Full Text] [Related]
25. The role of T lymphocytes in asthma. Kay AB Chem Immunol Allergy; 2006; 91():59-75. PubMed ID: 16354949 [TBL] [Abstract][Full Text] [Related]
26. Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach. Zaffini R; Gotte G; Menegazzi M Drug Des Devel Ther; 2018; 12():281-293. PubMed ID: 29483769 [TBL] [Abstract][Full Text] [Related]
27. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma. Hesse L; Petersen AH; Nawijn MC Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602 [TBL] [Abstract][Full Text] [Related]
28. Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes. Amin K; Janson C; Bystrom J Scand J Immunol; 2016 Aug; 84(2):75-85. PubMed ID: 27167590 [TBL] [Abstract][Full Text] [Related]
29. Effects of histamine on Th1/Th2 cytokine balance. Packard KA; Khan MM Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348 [TBL] [Abstract][Full Text] [Related]
31. Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and Its Potential for Therapy as a Target. Gao H; Ying S; Dai Y J Immunol Res; 2017; 2017():3743048. PubMed ID: 29359169 [TBL] [Abstract][Full Text] [Related]
32. What's new in asthma pathophysiology and immunopathology? Orihara K; Dil N; Anaparti V; Moqbel R Expert Rev Respir Med; 2010 Oct; 4(5):605-29. PubMed ID: 20923340 [TBL] [Abstract][Full Text] [Related]
33. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Oh CK; Raible D; Geba GP; Molfino NA Inflamm Allergy Drug Targets; 2011 Jun; 10(3):180-6. PubMed ID: 21428906 [TBL] [Abstract][Full Text] [Related]
34. Group 2 innate lymphoid cells in lung inflammation. Li BW; Hendriks RW Immunology; 2013 Nov; 140(3):281-7. PubMed ID: 23866009 [TBL] [Abstract][Full Text] [Related]
35. The immunology of asthma: Asthma phenotypes and their implications for personalized treatment. Borish L Ann Allergy Asthma Immunol; 2016 Aug; 117(2):108-14. PubMed ID: 27499537 [TBL] [Abstract][Full Text] [Related]
36. The role of the T cell in asthma. Robinson DS J Allergy Clin Immunol; 2010 Dec; 126(6):1081-91; quiz 1092-3. PubMed ID: 20709383 [TBL] [Abstract][Full Text] [Related]
38. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Oki S; Miyake S Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804 [TBL] [Abstract][Full Text] [Related]
39. Human asthma phenotypes: from the clinic, to cytokines, and back again. Bhakta NR; Woodruff PG Immunol Rev; 2011 Jul; 242(1):220-32. PubMed ID: 21682748 [TBL] [Abstract][Full Text] [Related]